AUDRA ROSE: Open Payments
NPI 1487877619 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 13 payments from 5 companies in 2025. Trend: 2023 $101 · 2024 $265 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $137 |
| Medtronic, Inc. | 1 | $101 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| CooperSurgical, Inc. | 1 | $18 |
Products named: INTERSTIM, QULIPTA, UBRELVY, MYFEMBREE, Veozah, LILETTA, Paragard T 380A.
Industry payments across ID — which companies pay providers there.
